Background: To assess the lipid-lowering effects and safety of atorvastatin and niacin in
patients with combined hyperlipidemia or isolated hypertriglyceridemia. Methods: We …

Objective: To study treatment persistence and mortality using a single-pill, fixed-dose
combination tablet compared with a two-pill combination for hypertension. Research design …

The goal of antihypertensive therapy is to reduce the risk associated with blood pressure
elevation. Although the choice of first-line drug therapy may exert some effects on different …

Pharmacological treatment recommended by guidelines for very high-risk patients with
established cardiovascular disease (CVD) includes lipid-lowering drugs, antihypertensive …

Mixed hyperlipidemia is characterized by both elevated total cholesterol and triglycerides. It
is estimated to account for 10% to 20% of patients with dyslipidemia. This study assessed …

Aim: Our objective was to investigate the effects and tolerability of fixed‐dose combination
therapy on blood pressure and LDL in adults without elevated blood pressure or lipid levels …

Statins, angiotensin-converting enzyme (ACE) inhibitors, and calcium channel blockers
(CCBs) have markedly changed the clinical progression of patients with coronary artery …

Once-daily administration of amlodipine, a long-acting dihydropyridine calcium-channel
blocker, and atenolol, a cardioselective [beta]-adrenoceptor blocking agent, were compared …

Amlodipine, a new long-acting dihydropyridine calcium antagonist, was compared with
hydrochlorothiazide (HCTZ) in 145 patients with mild to moderate hypertension. After 4 …

Hypertension and hypercholesterolemia are important modifiable risk factors for
cardiovascular disease (CVD). We examined the prevalence, treatment, and control of …